Free tool
FAERS Monitor: Bacteriostatic Sodium Chloride 0.9% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018800 or its brand name (Bacteriostatic Sodium Chloride 0.9% In Plastic Container, Sodium Chloride). Reports on generic versions are filed under their own applications.
Reports
76,168
Serious
61,067
80% of reports
Hospitalization
34,397
Death reported
6,460
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- myelosuppression5,526
- nausea5,455
- dyspnoea4,791
- off label use4,731
- headache4,431
- pyrexia4,335
- fatigue4,230
- vomiting3,896
- diarrhoea3,778
- pneumonia3,447
- pain2,979
- white blood cell count decreased2,947
- cough2,655
- drug ineffective2,511
- dizziness2,485
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 118 |
| 2005 | 182 |
| 2006 | 272 |
| 2007 | 249 |
| 2008 | 266 |
| 2009 | 413 |
| 2010 | 399 |
| 2011 | 585 |
| 2012 | 852 |
| 2013 | 690 |
| 2014 | 1,147 |
| 2015 | 2,155 |
| 2016 | 3,100 |
| 2017 | 2,518 |
| 2018 | 3,652 |
| 2019 | 5,136 |
| 2020 | 6,424 |
| 2021 | 5,764 |
| 2022 | 7,416 |
| 2023 | 7,804 |
| 2024 | 9,523 |
| 2025 | 9,950 |
| 2026 | 7,550 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,977,991 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| myelosuppressionSignal | 5,526 | 49.9 | 48.5 | 224,349 |
| white blood cell count decreasedSignal | 2,947 | 7.7 | 7.4 | 16,763 |
| pyrexiaSignal | 4,335 | 3.5 | 3.4 | 7,732 |
| pneumoniaSignal | 3,447 | 3.0 | 2.9 | 4,496 |
| coughSignal | 2,655 | 2.6 | 2.5 | 2,690 |
| dyspnoeaSignal | 4,791 | 2.3 | 2.3 | 3,778 |
| vomitingSignal | 3,896 | 2.3 | 2.2 | 2,899 |
| headache | 4,431 | 2.0 | 1.9 | 2,126 |
| nausea | 5,455 | 1.9 | 1.9 | 2,438 |
| diarrhoea | 3,778 | 1.6 | 1.6 | 918 |
| fatigue | 4,230 | 1.5 | 1.5 | 735 |
| off label use | 4,731 | 1.5 | 1.5 | 803 |
| dizziness | 2,485 | 1.4 | 1.3 | 262 |
| pain | 2,979 | 1.3 | 1.3 | 264 |
| drug ineffective | 2,511 | 0.5 | 0.5 | 1,147 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.